Avidian Wealth Enterprises LLC Has $579,000 Stock Position in Danaher Corporation $DHR

Avidian Wealth Enterprises LLC raised its stake in Danaher Corporation (NYSE:DHR) by 22.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,931 shares of the conglomerate’s stock after buying an additional 538 shares during the period. Avidian Wealth Enterprises LLC’s holdings in Danaher were worth $579,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Hills Bank & Trust Co boosted its position in Danaher by 0.3% in the first quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate’s stock valued at $3,693,000 after buying an additional 53 shares in the last quarter. Worth Financial Advisory Group LLC lifted its holdings in shares of Danaher by 4.6% during the second quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate’s stock worth $236,000 after purchasing an additional 53 shares during the period. Sageworth Trust Co lifted its holdings in shares of Danaher by 2.3% during the first quarter. Sageworth Trust Co now owns 2,404 shares of the conglomerate’s stock worth $493,000 after purchasing an additional 54 shares during the period. 1834 Investment Advisors Co. lifted its holdings in shares of Danaher by 3.3% during the first quarter. 1834 Investment Advisors Co. now owns 1,666 shares of the conglomerate’s stock worth $342,000 after purchasing an additional 54 shares during the period. Finally, Bruce G. Allen Investments LLC lifted its holdings in shares of Danaher by 13.1% during the second quarter. Bruce G. Allen Investments LLC now owns 467 shares of the conglomerate’s stock worth $92,000 after purchasing an additional 54 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insiders Place Their Bets

In other Danaher news, Director Teri List sold 2,778 shares of Danaher stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 11.10% of the company’s stock.

Danaher Trading Down 1.2%

DHR opened at $218.06 on Thursday. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $260.88. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The company has a market cap of $156.14 billion, a P/E ratio of 44.96, a price-to-earnings-growth ratio of 3.20 and a beta of 0.77. The company has a fifty day moving average price of $202.24 and a two-hundred day moving average price of $197.73.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.93%. The firm had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. During the same period in the previous year, the firm posted $1.71 earnings per share. The business’s revenue was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s payout ratio is 27.23%.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of recent research reports. TD Cowen lifted their price target on shares of Danaher from $250.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday. Bank of America cut their price target on shares of Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a report on Monday, September 22nd. Scotiabank upgraded shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price target on the stock in a report on Friday, July 11th. Rothschild Redb lowered shares of Danaher from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of Danaher from $235.00 to $250.00 and gave the company a “buy” rating in a report on Wednesday. Seventeen analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $243.39.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.